IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Boxer Capital, LLC

Q4 2015 Holdings

Filed 2016-02-16 | 15 holdings | $543.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aldeyra Therapeutics Inc(ALDX)COMMON01438T106$428.0K63,14678.8%
Mirati Therapeutics Inc(MRTXEUR)COMMON60468T105$63.9K2,023,23211.8%
Aquinox Pharmaceuticals IncCOMMON03842B101$10.1K809,4151.9%
Blueprint Medicines Corp(2L9)COMMON09627Y109$8.3K313,6261.5%
Seattle Genetics IncCOMMON812578102$7.2K160,0001.3%
Kura Oncology Inc(KURA)COMMON50127T109$5.5K654,5951.0%
Vitae Pharmaceuticals IncCOMMON92847N103$4.5K250,2700.8%
Aradigm Corp(ARDMEUR)COM NO PAR NEW038505400$4.4K1,101,5130.8%
Zogenix IncCOM NEW98978L204$3.3K225,0000.6%
Celladon CorpCOMMON15117E107$2.1K1,399,9910.4%
Akari Therapeutics PLCSPONSORED ADR00972G108$2.0K139,8990.4%
Sophiris BIO IncCOM NEW83578Q209$1.8K1,000,0000.3%
Nabriva Therapeutics AGSPONSORED ADR62957M104$1.7K176,7100.3%
Nexvet Biopharma PUB LTD CoORD SHSG6503X109$528154,8400.1%
Essa Pharma IncCOMMON29668H104$11928,1000.0%